Dr. Boutros Mikhail is a Toronto-based general practitioner whose medical career spans three decades and includes dermatology, cardiology, and endocrinology, alongside the treatment of chronic conditions such as heart disease and hypertension. Across multiple clinics in and outside Toronto, as well as hospital settings in rural Newfoundland, he has treated more than 2,200 patients using a patient-first approach that emphasizes transparent communication and culturally competent care. Dr. Mikhail earned his M.B.Ch.B. from the Faculty of Medicine in Cairo, along with a diploma in pediatrics from Cairo University and a distinction diploma in Practical Dermatology from Cardiff University, and he holds certifications including advanced cardiac life support and advanced trauma life support. He is a fellow of the College of Family Physicians of Canada and a member of the Ontario Medical Association, and he mentors medical students at the McMaster University Faculty of Medicine. His clinical experience with cardiovascular conditions directly informs the discussion below of hypertension’s relationship to heart failure.
Hypertension, also called high blood pressure, is a significant yet manageable risk for cardiac well-being. About one in three adults in the United States lives with this condition, but the lack of effective management leads to damage to the cardiovascular system. This strain is the primary entry point for the development of heart failure (HF).
The connection between hypertension and HF is clear and concerning. Studies reveal that high blood pressure is a major cause of HF, and when hypertension is properly managed, there is a reduced heart failure risk of about 64 percent. Hypertension raises the risk of cardiac failure by 71 percent compared with people with healthy readings.
Identifying the connection between these conditions is important in addressing hypertensive heart disease HHD – a condition resulting from years of sustained arterial pressure that causes damage, including muscle thickening and vessel stiffening. This damage often develops silently, leaving people unaware until the heart struggles to pump blood effectively.
Sustained high blood pressure places increased pressure on the heart, particularly the left ventricle, which must work harder to pump blood through the body. Over time, this pressure overload can trigger cardiac remodeling and cause the walls of the left ventricle to thicken. This change is known as left ventricular hypertrophy (LVH). Although this response can initially help the heart cope with the increased workload, persistent hypertension can eventually make the heart muscle stiffer and less efficient.
At the same time, changes in mechanical, hormonal, and inflammatory signaling can promote the buildup of excess collagen within the heart muscle, a process known as myocardial interstitial fibrosis. Together, LVH and fibrosis can impair the heart’s ability to relax and fill properly and may contribute to the development of heart failure.
Hypertension-related HF manifests in two forms: HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF). HFpEF occurs when heart muscles thicken and stiffen, preventing the chambers from relaxing and filling with blood properly. Conversely, HFrEF is an advanced-stage condition where the muscle becomes weak and stretched, meaning that the heart can no longer pump enough blood to meet the body’s requirements. This progression results from years of sustained and unmanaged arterial pressure.
Successful management requires attaining specific blood pressure (BP) goals through medicinal approaches and lifestyle modifications. Experts recommend a blood pressure reading below 130 mmHg for systolic BP and 80 mmHg for diastolic BP for individuals at high risk. Importantly, such a range should be consistent, not resulting from a single BP check. Various medications can lower blood pressure while protecting the heart muscle from further injury. Common options include inhibitors and blockers that relax blood vessels to improve blood flow.
Lifestyle habits are the primary defense against these conditions’ progression. The Dietary Approaches to Stop Hypertension (DASH) dietary plan emphasizes natural foods and reduced sodium to lower arterial resistance. Furthermore, regular aerobic activity may help improve the heart’s ability to fill with blood and reduce blood vessel stiffness.
Today, medical research into these conditions is shifting toward individualized care and investigating how inflammation impacts cardiac health. Some studies explore the gut-brain axis, suggesting that digestive health and the nervous system influence HF’s inflammatory triggers, leading to experimental therapies like nerve stimulation to reduce the body’s stress response. BP hikes’ timing is also a major diagnostic tool. High readings at night are now recognized as a more accurate HF predictor than day readings. Moreover, precision medicine – a model that considers a person’s genetics, environment, and lifestyle to select the most appropriate treatment – is beginning to allow for better detection of early heart scarring. By using specific blood markers to find microscopic damage, doctors can tailor patient treatment plans.
About Dr. Boutros Mikhail
Dr. Boutros Mikhail is a Toronto-based general practitioner with more than 20 years of experience treating patients across multiple clinics and hospital settings, including rural Newfoundland. His practice spans cardiology, dermatology, endocrinology, and chronic disease management, including hypertension and heart conditions. He holds an M.B.Ch.B. from Cairo, a distinction diploma in Practical Dermatology from Cardiff University, and certifications in advanced cardiac and trauma life support. He is a fellow of the College of Family Physicians of Canada and mentors students at McMaster University.
Read Also: flypapermagazine.com
